Sunil Healthcare Limited has submitted its mandatory compliance certificate under Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended March 31, 2026. The certificate demonstrates the company's adherence to regulatory requirements regarding share transfer processes and timelines.

Regulatory Submission Details

The compliance certificate was filed on April 16, 2026, and submitted to both The Bombay Stock Exchange Limited and The Calcutta Stock Exchange Ltd. Company Secretary and Compliance Officer Satyendu Patnaik (F-7736) signed and submitted the documentation on behalf of Sunil Healthcare Limited.

Compliance Verification Process

ATCS & Associates Practicing Company Secretaries conducted the compliance verification for the reporting period. The firm, headed by FCS Tara Chand Sharma (Partner, FCS No.: 5749, CP No.: 4078), examined all relevant documentation maintained by the company's Registrar & Transfer Agent.

Verification Scope

The compliance verification covered comprehensive examination of:

• Share Transfer Deeds
• Memorandum of Transfers
• Company registers and files
• Documentation maintained by Alankit Assignments Limited (RTA)

Compliance Certification

The practicing company secretary certified that Sunil Healthcare Limited has delivered share certificates relating to transfers received during the financial year 2025-26 within the prescribed timeline of fifteen days from the date of lodgment. This compliance extends to various share-related processes including transfer, sub-division, consolidation, renewal, exchange, and endorsement of calls/allotment monies.

The certificate confirms that all share certificates were issued within the regulatory timeframe, except for those rejected on technical grounds. This submission fulfills the company's obligation under SEBI LODR regulations and demonstrates its commitment to maintaining proper share transfer procedures and regulatory compliance.

Sunil Healthcare Limited has successfully obtained its quarterly compliance certificate under SEBI regulations for the fourth quarter of Financial Year 2025-26. The certificate confirms the company's adherence to regulatory requirements for share dematerialization processes during the quarter ending March 31, 2026.

SEBI Compliance Certification Details

The compliance certificate was issued under Regulation 74(5) of the SEBI (Depository and Participants) Regulations, 2018. This regulation mandates specific procedures for the dematerialization of physical share certificates and requires quarterly compliance reporting.

Registrar and Transfer Agent Confirmation

Alankit Assignments Limited, serving as the company's Registrar and Transfer Agent (RTA), issued the compliance certificate on April 4, 2026. The certificate was signed by Kamal Garg, General Manager at Alankit Assignments Limited. The RTA confirmed two critical compliance aspects:

• The securities comprised in the certificates have been properly listed on the Stock Exchanges
• Physical certificates have been duly verified, mutilated, cancelled, and the depository name has been substituted in records as the registered owner

Stock Exchange Submission

Company Secretary and Compliance Officer Satyendu Pattnaik submitted the compliance certificate to both major stock exchanges on April 7, 2026. The submission was made to:

• The Bombay Stock Exchange Limited (Company Code: 537253)
• The Calcutta Stock Exchange Limited

The digital submission was completed with proper authentication, ensuring regulatory compliance and transparency in corporate governance practices.

Corporate Information

Sunil Healthcare Limited operates from its registered office at Vijay Tower, New Delhi, with CIN number L24302DL1973PLC189662. The company maintains regular compliance with SEBI regulations through its appointed RTA, Alankit Assignments Limited, which holds multiple SEBI registrations for various financial services.